Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Molecular Psychiatry

• Publication date

  2014-03-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1038/mp.2013.42PMID 23587880PMCID PMC4756476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pitt-Hopkins syndrome

  2020cited by this paper
• Neurodevelopmental features in 2q23.1 microdeletion syndrome: Report of a new patient with intractable seizures and review of literature

  2012cited by this paper
• Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations

  2012cited by this paper
• 2q23.1 microdeletion of the MBD5 gene in a female with seizures, developmental delay and distinct dysmorphic features.

  2012cited by this paper
• Phenotypic variability of atypical 22q11.2 deletions not including TBX1

  2012cited by this paper
• Development, cognition, and behaviour in Pitt–Hopkins syndrome

  2012cited by this paper
• Complex reorganization and predominant non-homologous repair following chromosomal breakage in karyotypically balanced germline rearrangements and transgenic integration

  2012cited by this paper
• Phenotypic heterogeneity of genomic disorders and rare copy-number variants.

  2012cited by this paper
• Evolution and Functional Impact of Rare Coding Variation from Deep Sequencing of Human Exomes

  2012cited by this paper
• Update on Kleefstra Syndrome

  2012cited by this paper
• Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries.

  2012cited by this paper
• Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability.

  2012cited by this paper
• Severe intellectual disability and autistic features associated with microduplication 2q23.1

  2011cited by this paper
• 2q23 de novo microdeletion involving the MBD5 gene in a patient with developmental delay, postnatal microcephaly and distinct facial features

  2011cited by this paper
• Ophthalmic findings in Angelman syndrome.

  2011cited by this paper
• Systematic review of the clinical and genetic aspects of Prader-Willi syndrome

  2011cited by this paper
• Rett syndrome: clinical and genetic features

  2011cited by this paper
• Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder.

  2011cited by this paper
• Physical health problems in adults with Prader–Willi syndrome

  2011cited by this paper
• Pitt-Hopkins Syndrome

  2011cited by this paper
• The Pitt‐Hopkins syndrome: Report of 16 new patients and clinical diagnostic criteria

  2011cited by this paper
• Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus

  2011influential reference
• Next-generation sequencing strategies enable routine detection of balanced chromosome rearrangements for clinical diagnostics and genetic research.

  2011cited by this paper
• The 2q23.1 microdeletion syndrome: clinical and behavioural phenotype

  2010cited by this paper
• Haploinsufficiency of MBD5 associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and seizures

  2010cited by this paper
• The Human Proteins MBD5 and MBD6 Associate with Heterochromatin but They Do Not Bind Methylated DNA

  2010cited by this paper
• Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

  2010cited by this paper
• Rett syndrome: Revised diagnostic criteria and nomenclature

  2010cited by this paper
• Clinical and genetic aspects of Angelman syndrome

  2010cited by this paper
• Thyroid axis dysfunction in patients with Prader‐Willi syndrome during the first 2 years of life

  2010cited by this paper
• The 2q23.1 microdeletion syndrome: clinical and behavioural phenotype

  2010cited by this paper
• Functional impact of global rare copy number variation in autism spectrum disorders

  2010cited by this paper
• Environmental analysis.

  2009cited by this paper
• DNA methylation and methyl-CpG binding proteins: developmental requirements and function

  2009cited by this paper
• Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype

  2009cited by this paper
• Small Deletions of SATB2 Cause Some of the Clinical Features of the 2q33.1 Microdeletion Syndrome

  2009cited by this paper
• 2q23.1 microdeletion identified by array comparative genomic hybridisation: an emerging phenotype with Angelman-like features?

  2008cited by this paper
• Association between microdeletion and microduplication at 16p11.2 and autism.

  2008cited by this paper
• Copy-number variations measured by single-nucleotide-polymorphism oligonucleotide arrays in patients with mental retardation.

  2007cited by this paper
• The chromosome 9q subtelomere deletion syndrome

  2007cited by this paper
• Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions.

  2007cited by this paper
• Use of array-based technology in the practice of medical genetics

  2007cited by this paper
• Cornelia de Lange syndrome: Clinical review, diagnostic and scoring systems, and anticipatory guidance

  2007cited by this paper
• Gender, genotype, and phenotype differences in Smith–Magenis syndrome: a meta‐analysis of 105 cases

  2007cited by this paper
• Cryptic deletions are a common finding in “balanced” reciprocal and complex chromosome rearrangements: a study of 59 patients

  2007cited by this paper
• Adaptive and Maladaptive Behavior in Children with Smith-Magenis Syndrome

  2006cited by this paper
• Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2).

  2006cited by this paper
• Rett Syndrome: Model of Neurodevelopmental Disorders

  2005cited by this paper
• Diagnostic genome profiling in mental retardation.

  2005cited by this paper
• Ophthalmologic findings in the Cornelia de Lange Syndrome.

  2005cited by this paper
• A novel microdeletion, del(2)(q22.3q23.3) in a mentally retarded patient, detected by array‐based comparative genomic hybridization

  2004cited by this paper
• High Incidence of Hip Dysplasia but Not Slipped Capital Femoral Epiphysis in Patients With Prader-Willi Syndrome

  2004cited by this paper
• Theoretical and practical advances in genome halving

  2004cited by this paper
• Role of TBX1 in human del22q11.2 syndrome.

  2003cited by this paper
• Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities.

  2003cited by this paper
• The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.

  2001cited by this paper
• Sleep disturbance in Smith-Magenis syndrome (del 17 p11.2).

  1998cited by this paper
• Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics.

  1997cited by this paper
• Ophthalmic manifestations of Smith-Magenis syndrome.

  1996cited by this paper
• Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2)

  1996cited by this paper
• de Lange syndrome: a clinical review of 310 individuals.

  1993cited by this paper
• Rett syndrome.

  1990cited by this paper
• Ophthalmologic findings in the Cornelia de Lange syndrome.

  1990cited by this paper
• Ophthalmologic features of Prader-Willi syndrome.

  1988cited by this paper
• RETT SYNDROME

  1986cited by this paper

• Transcriptomic Characterization of the Porcine Urinary Bladder Trigone Following Intravesical Administration of Resiniferatoxin: Insights from High-Throughput Sequencing

  2025cites this paper
• Noncoding de novo mutations in SCN2A are associated with autism spectrum disorders

  2025cites this paper
• Is it worth a CGH array? MBD5 haploinsufficiency and clinical variability in MBD5-associated neurodevelopmental disorder: a case report

  2025cites this paper
• A Unique Case of MBD5 and CCM2 Deletions Leading to a Severe Neurological Phenotype With Prolonged Status Epilepticus

  2025cites this paper
• Noncoding de novo mutations in SCN2A are associated with autism spectrum disorders

  2024cites this paper
• Unveiling genetic insights: Array-CGH and WES discoveries in a cohort of 122 children with essential autism spectrum disorder

  2024cites this paper
• Comparative meta-analysis of transcriptomic studies in spinal muscular atrophy: comparison between tissues and mouse models

  2024cites this paper
• Association between the copy number variations of Methyl-CpG binding domain family and schizophrenia.

  2024cites this paper
• Oligogenic inheritance in severe adult obesity

  2024cites this paper
• Synonymous alterations of cancer-associated Trp53 CpG mutational hotspots cause fatal developmental jaw malocclusions but no tumors in knock-in mice

  2023cites this paper
• A Multicenter Analysis of Abnormal Chromosomal Microarray Findings in Congenital Heart Disease

  2023cites this paper
• Case report of a female with bipolar disorder and MBD5 deletion

  2022cites this paper
• Life cycle patterns of professional performance from Go world champions

  2022cites this paper
• Developmental disorders caused by haploinsufficiency of transcriptional regulators: a perspective based on cell fate determination

  2022cites this paper
• Germline mosaicism in a family with MBD5 haploinsufficiency

  2022influential citation
• Chromosomal Microarray Analysis as First-Tier Genetic Test for Schizophrenia

  2021cites this paper
• Early-Onset Dementia Associated with a Heterozygous, Nonsense, and de novo Variant in the MBD5 Gene

  2021cites this paper
• Chromatin Imbalance as the Vertex Between Fetal Valproate Syndrome and Chromatinopathies

  2021cites this paper
• Phenotypic Spectrum of Seizure Disorders in MBD5-Associated Neurodevelopmental Disorder

  2021cites this paper
• Composite Sleep Problems Observed Across Smith–Magenis Syndrome, MBD5-Associated Neurodevelopmental Disorder, Pitt–Hopkins Syndrome, and ASD

  2020cites this paper
• On the path toward personalized medicine: implications of pharmacogenetic studies of alcohol use disorder medications

  2020cites this paper
• Pleiotropy and Cross-Disorder Genetics Among Psychiatric Disorders.

  2020cites this paper
• Transcriptional consequences of MBD5 disruption in mouse brain and CRISPR-derived neurons

  2020cites this paper
• Modeling neuronal consequences of autism-associated gene regulatory variants with human induced pluripotent stem cells

  2020cites this paper
• Structural genomic variation in human disease

  2019cites this paper
• Neuropsychiatric decompensation in adolescents and adults with Phelan-McDermid syndrome: a systematic review of the literature

  2019cites this paper
• A novel MBD5 mutation in an intellectually disabled adult female patient with epilepsy: Suggestive of early onset dementia?

  2019cites this paper
• STRUCTURAL GENOMIC VARIATION IN HUMAN DISEASE THESIS FOR DOCTORAL DEGREE ( Ph . D . )

  2019cites this paper
• Rare Copy Number Variation In an Extremely Impulsively Violent Males:

  2018cites this paper
• Burden of de novo mutations and inherited rare single nucleotide variants in children with sensory processing dysfunction

  2018cites this paper
• Rare copy number variation in extremely impulsively violent males

  2018cites this paper
• Next Generation Sequencing of Prenatal Structural Chromosomal Rearrangements Using Large-Insert Libraries.

  2018cites this paper
• Genetic tests in major psychiatric disorders—integrating molecular medicine with clinical psychiatry—why is it so difficult?

  2017cites this paper
• Variable phenotype expression in a family segregating microdeletions of the NRXN1 and MBD5 autism spectrum disorder susceptibility genes

  2017cites this paper
• The Yin and Yang of Autism Genetics: How Rare De Novo and Common Variations Affect Liability.

  2017cites this paper
• High-resolution copy number variation analysis of schizophrenia in Japan

  2017cites this paper
• Diagnostic exome sequencing identifies a heterozygous MBD5 frameshift mutation in a family with intellectual disability and epilepsy.

  2017influential citation
• Defining the diverse spectrum of inversions, complex structural variation, and chromothripsis in the morbid human genome

  2017cites this paper
• Inherited 2q23.1 microdeletions involving the MBD5 locus

  2017cites this paper
• Utilisation du séquençage à haut débit dans l’identification des gènes prédisposant à l’épilepsie et aux syndromes neurocutanés

  2017cites this paper
• Copy number variants analysis in a cohort of isolated and syndromic developmental delay/intellectual disability reveals novel genomic disorders, position effects and candidate disease genes

  2017cites this paper
• Rearrangements of 7q11.23: disorders of the epigenome

  2017cites this paper
• Next Generation Sequencing in Neurology and Psychiatry

  2016cites this paper
• Chromosomal Microarrays: Understanding Genetics of Neurodevelopmental Disorders and Congenital Anomalies

  2016cites this paper
• Pathogenic copy number variants and SCN1A mutations in patients with intellectual disability and childhood-onset epilepsy

  2016cites this paper
• Genome-wide characteristics of de novo mutations in autism

  2016cites this paper
• Investigation of single-nucleotide variants in MBD5 associated with autism spectrum disorders and schizophrenia phenotypes

  2016cites this paper
• Clinical and Molecular Aspects of MBD5-Associated Neurodevelopmental Disorder (MAND)

  2016cites this paper
• DNA Methylation and Adult Neurogenesis

  2016cites this paper
• IQSEC2 and X-linked syndromal intellectual disability

  2016cites this paper
• Genome Sequencing of Autism-Affected Families Reveals Disruption of Putative Noncoding Regulatory DNA.

  2016cites this paper
• Clinical and Molecular Aspects of MBD5-Associated Neurodevelopmental Disorder (MAND)

  2016cites this paper
• Clinical and Molecular Characterization of a Patient with a 2p22.3 to 2q24.1 Deletion

  2016cites this paper
• Estudio de variantes estructurales del genoma humano asociadas a trastornos del neurodesarrollo

  2016cites this paper
• Whole genome/exome sequencing in mood and psychotic disorders

  2015cites this paper
• Methyl-CpG-binding domain proteins: readers of the epigenome.

  2015cites this paper
• Phenotypic and Molecular Convergence of 2q23.1 Deletion Syndrome with Other Neurodevelopmental Syndromes Associated with Autism Spectrum Disorder

  2015cites this paper
• Chromatin Regulatory Complexes from an Interaction Proteomics Perspective. Chromatine-Regulerende Complexen vanuit een Interactie-Proteomics Perspectief

  2015cites this paper
• Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci.

  2015cites this paper
• MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith–Magenis and fragile X syndromes

  2014cites this paper
• MBD5 regulates iron metabolism via methylation‐independent genomic targeting of Fth1 through KAT2A in mice

  2014cites this paper
• If not Angelman, what is it? a review of Angelman‐like syndromes

  2014cites this paper
• Chromatin regulators, phenotypic robustness, and autism risk

  2014cites this paper
• Disruption of the ASTN2/TRIM32 locus at 9q33.1 is a risk factor in males for autism spectrum disorders, ADHD and other neurodevelopmental phenotypes.

  2014cites this paper
• A genomic copy number variant analysis implicates the MBD5 and HNRNPU genes in Chinese children with infantile spasms and expands the clinical spectrum of 2q23.1 deletion

  2014cites this paper
• Autism Spectrum Disorder Genetics: Diverse Genes with Diverse Clinical Outcomes

  2014cites this paper
• Transcriptional consequences of 16p11.2 deletion and duplication in mouse cortex and multiplex autism families.

  2014cites this paper
• Abnormalities of the DNA Methylation Mark and Its Machinery: An Emerging Cause of Neurologic Dysfunction

  2014cites this paper
• Design of Large‐Insert Jumping Libraries for Structural Variant Detection Using Illumina Sequencing

  2014cites this paper
• The genetics of cognitive epigenetics.

  2014cites this paper
• Intragenic MBD5 familial deletion variant does not negatively impact MBD5 mRNA expression

  2014cites this paper
• Mendelian disorders of the epigenetic machinery: tipping the balance of chromatin states.

  2014cites this paper
• Deciphering the pathogenic consequences of chromosomal aberrations in human genetic disease

  2014cites this paper
• Spectrum Disorders, ADHD and other neurodevelopmental phenotypes

  2013cites this paper
• CNVs analysis in a cohort of isolated and syndromic DD / ID reveals novel genomic disorders , position effects and candidate disease genes

  year unknowncites this paper